MySheen

The transformation and upgrading of China's veterinary drug industry is on its way.

Published: 2024-11-05 Author: mysheen
Last Updated: 2024/11/05, In recent years, the international veterinary drug market has entered a period of monopoly development, and multinational enterprises have merged and reorganized successively. According to the data, the market share of the world's top five animal health products companies increased from 34% in 1998 to 65% in 2009, and concentration increased by 31% in 11 years.

In recent years, the international veterinary drug market has entered a period of monopoly development, and multinational enterprises have merged and reorganized successively. According to the data, the market share of the world's top five animal health products companies increased from 34% in 1998 to 65% in 2009, and concentration increased by 31% in 11 years.

In recent years, the number of veterinary drug enterprises in China has increased rapidly. Although the number of enterprises has partially decreased in the past two years, the volume is still huge.

According to the statistics of China Veterinary Drug Association, by the end of 2011, there were 1713 veterinary drug manufacturers in China, including 84 biological products enterprises. Compared with 2007, the number increased by 367 and 30 respectively. By the end of 2012, there were 1791 veterinary drug manufacturers in China, including 68 biological products enterprises. The latest data show that by the end of 2013, there were 1661 veterinary drug enterprises, including 72 biological products enterprises and 1589 chemical drug enterprises.

The data clearly show that there are many veterinary chemical drug enterprises in China, with small and medium-sized enterprises and small enterprises accounting for about 90% of the total. From 2008 to 2010, the sales concentration index CR10 of chemical pharmaceutical enterprises was 15.13%, 16% and 18.75% respectively, although it has increased, but the absolute concentration is still very low.

 
0